New skin patch could make grafts more flexible and less scarred
NCT ID NCT02090361
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding a collagen-elastin dermal matrix to standard skin grafts improves skin flexibility and reduces scarring. 92 adults with skin loss from injury or surgery received either a graft with the matrix or a graft alone. The main goal was to measure skin foldability at one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- collagen-elastin dermal matrix
- What this could lead to
- If it works, this could make skin grafts more flexible and less scarred, improving appearance and function.
- What could go wrong
- This is a completed early-stage study with 92 participants, so results may not apply to everyone. The matrix may not improve outcomes over standard grafts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLLAGEN -ELASTIN MATRIX are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU d'Amiens
Amiens, France
-
CHU de Caen
Caen, France
-
CHU de Lille
Lille, France
-
UH Rouen
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.